Evidone seed round

Evidone SA has developed a patented technology that leverages robotics, computer vision, and machine learning. It is designed for deployment in clinical settings to reduce costs and enhance the efficiency of operating rooms and other hospital operations.

The company is currently working on pilot installations at selected institutions to refine its value proposition and prioritize the product roadmap.

Following the pilot phase, Evidone SA plans to raise seed funding with the following details:

• Timing: H1 2025

• Amount: 2 million CHF

• Use of funds: Product development leading up to market entry

Please reach out if you are interested in learning more.